MECHANISMS OF RENAL MALIGNANCY IN TUBEROUS SCLEROSIS
$86,417R01FY2001DKNIH
Fox Chase Cancer Center, Philadelphia PA
Investigators
Linked publications & trials
Paper 27753446Paper 23526212Paper 21746920Paper 20038815Paper 19234517Paper 17914450Paper 17162089Paper 17005952Paper 16803888Paper 16339216Paper 15856327Paper 15579029Paper 15150271Paper 14551205Paper 12922981Paper 12547707Paper 12466966Paper 12205112Paper 11904337
Abstract
DESCRIPTION: (Adapted from the investigator's abstract) The long-term goal is to elucidate the functions of hamartin and tuberin. Specific Aims include 1) to identify the germline "first hit" and somatic "second hit" mutations in TSC-associated renal cell carcinomas, 2) to identify other somatic genetic events involved in the development of renal cell carcinoma in TSC patients, 3) to define the hamartin-tuberin interaction domain and to determine the effects of naturally occurring mutations on the hamartin-tuberin interaction, and 4) to determine the role of hamartin in cell cycle regulation.
View original record on NIH RePORTER →